Back    Zoom +    Zoom -
CN Improves Drug Pricing Formation Mechanism to Optimize Initial Pricing for Innovative Drugs
Recommend
35
Positive
67
Negative
23
The General Office of China's State Council has issued its opinions on improving the drug pricing formation mechanism, stating that it will refine pricing policies for key segments at different stages after a drug's launch.

The opinions also proposed measures including optimizing the initial pricing mechanism for innovative and other newly launched drugs, leveraging medical insurance payment standards to guide drug price formation, improving the pricing mechanism for centralized volume-based drug procurement, and enhancing the management of listed online drug prices.

Related NewsUBS: WUXI APPTEC (02359.HK) Zero-Coupon Convertible Bond Issuance Slightly Positive, Reflects Management Confidence

Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details

AASTOCKS Financial News